Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice
- PMID: 19111716
- DOI: 10.1016/j.ejphar.2008.12.020
Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice
Abstract
The muscarinic acetylcholine receptor (mAChR) agonist, xanomeline, attenuates amphetamine-induced activity in WT mice. This effect is abolished in mice lacking the M(4) muscarinic acetylcholine receptor (M(4) mAChR KO) and partially attenuated in mice lacking M(1) muscarinic acetylcholine receptor (M(1) mAChR KO). Collectively, these data suggest that the efficacy exhibited by xanomeline in the mouse amphetamine-induced hyperactivity model, is mediated predominantly by M(4) muscarinic acetylcholine receptors, and that M(1) muscarinic acetylcholine receptors may play a more minor role. This supports the hypothesis that activation of M(4), and to a lesser extent M(1) muscarinic acetylcholine receptors, may represent a potential target for the treatment of psychosis seen in schizophrenia.
Similar articles
-
Involvement of a subpopulation of neuronal M4 muscarinic acetylcholine receptors in the antipsychotic-like effects of the M1/M4 preferring muscarinic receptor agonist xanomeline.J Neurosci. 2011 Apr 20;31(16):5905-8. doi: 10.1523/JNEUROSCI.0370-11.2011. J Neurosci. 2011. PMID: 21508215 Free PMC article.
-
The muscarinic M1/M4 receptor agonist xanomeline exhibits antipsychotic-like activity in Cebus apella monkeys.Neuropsychopharmacology. 2003 Jun;28(6):1168-75. doi: 10.1038/sj.npp.1300151. Epub 2003 Mar 26. Neuropsychopharmacology. 2003. PMID: 12700711
-
Low-affinity M(2) receptor binding state mediates mouse atrial bradycardia: comparative effects of carbamylcholine and the M(1) receptor agonists sabcomeline and xanomeline.J Pharmacol Exp Ther. 2001 Mar;296(3):818-24. J Pharmacol Exp Ther. 2001. PMID: 11181912
-
Discovery and Development of Muscarinic Acetylcholine M4 Activators as Promising Therapeutic Agents for CNS Diseases.Chem Pharm Bull (Tokyo). 2018;66(1):37-44. doi: 10.1248/cpb.c17-00413. Chem Pharm Bull (Tokyo). 2018. PMID: 29311510 Review.
-
Xanomeline and the antipsychotic potential of muscarinic receptor subtype selective agonists.CNS Drug Rev. 2003 Summer;9(2):159-86. doi: 10.1111/j.1527-3458.2003.tb00247.x. CNS Drug Rev. 2003. PMID: 12847557 Free PMC article. Review.
Cited by
-
Muscarinic Acetylcholine Receptor Subtypes as Potential Drug Targets for the Treatment of Schizophrenia, Drug Abuse and Parkinson's Disease.ACS Chem Neurosci. 2012;3(2):80-89. doi: 10.1021/cn200110q. ACS Chem Neurosci. 2012. PMID: 22389751 Free PMC article.
-
Alpha7 nicotinic acetylcholine receptor is a target in pharmacology and toxicology.Int J Mol Sci. 2012;13(2):2219-2238. doi: 10.3390/ijms13022219. Epub 2012 Feb 17. Int J Mol Sci. 2012. PMID: 22408449 Free PMC article. Review.
-
Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics.Psychopharmacology (Berl). 2010 Oct;212(2):155-70. doi: 10.1007/s00213-010-1938-0. Epub 2010 Jul 31. Psychopharmacology (Berl). 2010. PMID: 20676613
-
Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100.Neuropsychopharmacology. 2014 Jun;39(7):1578-93. doi: 10.1038/npp.2014.2. Epub 2014 Jan 20. Neuropsychopharmacology. 2014. PMID: 24442096 Free PMC article.
-
Muscarinic receptors: their roles in disorders of the central nervous system and potential as therapeutic targets.CNS Neurosci Ther. 2012 May;18(5):369-79. doi: 10.1111/j.1755-5949.2011.00249.x. Epub 2011 Feb 26. CNS Neurosci Ther. 2012. PMID: 22070219 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials